A 51-year-old woman was evaluated for rapidly progressive bilateral lower extremity (LE) claudication. Four months prior, she developed bilateral shoulder and hip girdle aching and stiffness. Laboratory studies revealed elevated markers of inflammation and autoimmune serologies were negative. A diagnosis of polymyalgia rheumatica (PMR) was made and prednisone 15 mg daily was started with good response. Two months later, she developed acute, progressive, bilateral LE claudication. Cranial symptoms of arteritis were absent. The patient's only cardiovascular risk factor was hypertension. Examination revealed decreased pedal pulses without large vessel bruits. Ankle-brachial indices (ABI) were obtained at rest and with exercise and showed severe bilateral multilevel arterial occlusive disease. Ankle ABIs were 0.39 (right) and 0.37 (left) at rest and decreased to 0.21 with exercise. Treadmill exercise had to be terminated after 2 minutes due to symptoms of bilateral buttock and lower extremity claudication. A computed tomography angiogram (CTA) with bilateral LE run-off showed long segments of high-grade narrowing of bilateral superficial femoral arteries with wall thickening. A temporal artery biopsy was negative. Serologic evaluation for autoimmune connective tissue diseases (anti-nuclear antibodies, antibodies to extractable nuclear antigens), studies for anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis, antiphospholipid antibody syndrome, chronic hepatitis and cryoglobulinemia were all negative. A CTA of the chest and abdomen was negative for evidence of vasculitis. Positron emission tomography-computed tomography (PET-CT) showed increased fluorodeoxyglucose (FDG) uptake from the distal common femoral arteries through the superficial femoral arteries (Panel A: FDG-PET; Panels B and C: hybrid image with CTA), popliteal arteries and tibioperoneal trunks bilaterally consistent with LE vasculitis. FDG uptake was absent in the aorta, iliac arteries and upper extremity arteries. A diagnosis of LE large-vessel vasculitis was made and prednisone was increased to 60 mg daily.
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While LE involvement can be part of a systemic largevessel vasculitis, 1,2 isolated LE vasculitis, as seen in our patient, is distinctly uncommon. Imaging modalities including CTA, MRA and PET scans are helpful in diagnosis. 3 Glucocorticoids remain the treatment of choice and should be initiated promptly. In general, revascularization procedures should be deferred when the inflammatory process is active. 4 Surgical/revascularization options may need to be reconsidered in patients with refractory symptoms despite appropriate medical therapy.
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